-
The country’s COVID-19 vaccine strategy could be getting an overhaul. An FDA panel met Thursday and recommended a proposal that would make getting a COVID-19 shot an annual event.
-
Advisers to the Food and Drug Administration supported boosters of the Pfizer-BioNTech COVID-19 vaccine for a smaller group of people after they voted against recommending it for anyone 16 and older.
-
Menthol has been the last allowable flavor in cigarettes, and the FDA says marginalized communities are far more likely to use these products.
-
A panel of experts advising the Food and Drug Administration weighs the safety and effectiveness of the COVID-19 vaccine from Moderna in a daylong public…
-
Advisers to the Food and Drug Administration voted 20-0 to recommend that the agency authorize Moderna's vaccine for emergency use during the pandemic. There was a single abstention.
-
The new tests produce results completely at home within 15 minutes. Experts say they could be a 'game-changer' in helping people find out quickly if they need to isolate.
-
Pfizer and BioNTech's vaccine is the first to receive an emergency authorization from the Food and Drug Administration. Officials say it may be ready for widespread inoculations within days.
-
A panel of experts advising the Food and Drug Administration will weigh the safety and effectiveness of the COVID-19 vaccine from Pfizer and BioNTech in a…
-
In a 17-4 vote, an expert committee concluded that the scientific evidence supports the authorization of the COVID-19 vaccine from Pfizer and BioNTech for emergency use during the pandemic.
-
The Food and Drug Administration finds "no specific safety concerns" that would stand in the way of authorization of the vaccine for emergency use. Effectiveness is 95% after two doses.